Panagene Inc (046210) - Total Liabilities

Latest as of September 2025: ₩24.65 Billion KRW ≈ $16.70 Million USD

Based on the latest financial reports, Panagene Inc (046210) has total liabilities worth ₩24.65 Billion KRW (≈ $16.70 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 046210 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Panagene Inc - Total Liabilities Trend (2005–2024)

This chart illustrates how Panagene Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 046210 asset base.

Panagene Inc Competitors by Total Liabilities

The table below lists competitors of Panagene Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Spinnova Oy HE:SPINN	Finland	€12.00 Million
Radiopharm Theranostics Ltd AU:RAD	Australia	AU$37.81 Million
Carmit TA:CRMT	Israel	ILA202.22 Million
D P Wires Limited NSE:DPWIRES	India	Rs-2.48 Billion
Live Ventures Inc NASDAQ:LIVE	USA	$293.93 Million
Silver Bear Resources Inc TO:SBR	Canada	CA$469.50 Million
Carbonxt Group Ltd AU:CG1	Australia	AU$23.04 Million
Tondo Smart Ltd TA:TNDO	Israel	ILA35.41 Million

Liability Composition Analysis (2005–2024)

This chart breaks down Panagene Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Panagene Inc to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.21	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Panagene Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Panagene Inc (2005–2024)

The table below shows the annual total liabilities of Panagene Inc from 2005 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩33.57 Billion ≈ $22.75 Million	+22.77%
2023-12-31	₩27.34 Billion ≈ $18.53 Million	+816.19%
2022-12-31	₩2.98 Billion ≈ $2.02 Million	+44.46%
2021-12-31	₩2.07 Billion ≈ $1.40 Million	-4.43%
2020-12-31	₩2.16 Billion ≈ $1.46 Million	+36.64%
2019-12-31	₩1.58 Billion ≈ $1.07 Million	-79.65%
2018-12-31	₩7.77 Billion ≈ $5.27 Million	-3.51%
2017-12-31	₩8.06 Billion ≈ $5.46 Million	-32.42%
2016-12-31	₩11.92 Billion ≈ $8.08 Million	-28.76%
2015-12-31	₩16.73 Billion ≈ $11.34 Million	+0.92%
2012-12-31	₩16.58 Billion ≈ $11.24 Million	-37.39%
2011-12-31	₩26.48 Billion ≈ $17.95 Million	+22.33%
2010-12-31	₩21.65 Billion ≈ $14.67 Million	+44.59%
2009-12-31	₩14.97 Billion ≈ $10.15 Million	-38.62%
2008-12-31	₩24.39 Billion ≈ $16.53 Million	+47.48%
2007-12-31	₩16.54 Billion ≈ $11.21 Million	-40.36%
2006-12-31	₩27.73 Billion ≈ $18.79 Million	-43.96%
2005-12-31	₩49.49 Billion ≈ $33.54 Million	--

About Panagene Inc

KQ:046210 Korea Biotechnology & Medical Research

Market Cap

$24.54 Million

₩36.22 Billion KRW

Market Cap Rank

#24535 Global

#1756 in Korea

Share Price

₩1127.00

Change (1 day)

-3.59%

52-Week Range

₩999.00 - ₩2650.00

All Time High

₩12000.00